228 related articles for article (PubMed ID: 28635927)
1. [Mechanisms of corneal neovascularization and modern options for its suppression].
Mamikonyan VR; Pivin EA; Krakhmaleva DA
Vestn Oftalmol; 2016; 132(4):81-87. PubMed ID: 28635927
[TBL] [Abstract][Full Text] [Related]
2. Proangiogenic Function of T Cells in Corneal Transplantation.
Di Zazzo A; Tahvildari M; Subbarayal B; Yin J; Dohlman TH; Inomata T; Mashaghi A; Chauhan SK; Dana R
Transplantation; 2017 Apr; 101(4):778-785. PubMed ID: 27490416
[TBL] [Abstract][Full Text] [Related]
3. [Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options].
Cursiefen C; Seitz B; Dana MR; Streilein JW
Ophthalmologe; 2003 Apr; 100(4):292-9. PubMed ID: 12682761
[TBL] [Abstract][Full Text] [Related]
4. [Corneal neovascularization: epidemiological, physiopathological, and clinical features].
Benayoun Y; Casse G; Forte R; Dallaudière B; Adenis JP; Robert PY
J Fr Ophtalmol; 2013 Sep; 36(7):627-39. PubMed ID: 23891320
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery.
Gerten G
Cornea; 2008 Dec; 27(10):1195-9. PubMed ID: 19034142
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory corneal neovascularization: etiopathogenesis.
Clements JL; Dana R
Semin Ophthalmol; 2011; 26(4-5):235-45. PubMed ID: 21958169
[TBL] [Abstract][Full Text] [Related]
7. Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty.
Nirankari VS; Baer JC
Ophthalmology; 1986 Oct; 93(10):1304-9. PubMed ID: 2431371
[TBL] [Abstract][Full Text] [Related]
8. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
Benelli U; Ross JR; Nardi M; Klintworth GK
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459
[TBL] [Abstract][Full Text] [Related]
9. Treatments for corneal neovascularization: a review.
Gupta D; Illingworth C
Cornea; 2011 Aug; 30(8):927-38. PubMed ID: 21389854
[TBL] [Abstract][Full Text] [Related]
10. Corneal angiogenic privilege and its failure.
Di Zazzo A; Gaudenzi D; Yin J; Coassin M; Fernandes M; Dana R; Bonini S
Exp Eye Res; 2021 Mar; 204():108457. PubMed ID: 33493471
[TBL] [Abstract][Full Text] [Related]
11. [Anti(lymph)angiogenic preconditioning prior to keratoplasty].
Cursiefen C; Regenfuss B; Hos D; Bucher F; Steven P; Heindl LM; Bock F
Klin Monbl Augenheilkd; 2013 May; 230(5):500-4. PubMed ID: 23695846
[TBL] [Abstract][Full Text] [Related]
12. Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty.
Cursiefen C; Martus P; Nguyen NX; Langenbucher A; Seitz B; Küchle M
Cornea; 2002 Oct; 21(7):648-52. PubMed ID: 12352079
[TBL] [Abstract][Full Text] [Related]
13. Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes.
Rocher N; Behar-Cohen F; Pournaras JA; Naud MC; Jeanny JC; Jonet L; Bourges JL
Mol Vis; 2011 Jan; 17():104-12. PubMed ID: 21245949
[TBL] [Abstract][Full Text] [Related]
14. [Fibrinolysis components and angiogenesis regulation by example of burn-induced corneal neovascularization in rabbits].
Chesnokova NB; Aĭsina RB; Mukhametova LI; Pavlenko TA; Gulin DA; Beznos OV
Vestn Oftalmol; 2012; 128(4):62-5. PubMed ID: 22994111
[TBL] [Abstract][Full Text] [Related]
15. Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman.
Regenfuss B; Bock F; Parthasarathy A; Cursiefen C
Lymphat Res Biol; 2008; 6(3-4):191-201. PubMed ID: 19093792
[TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF Treatment in Corneal Diseases.
Giannaccare G; Pellegrini M; Bovone C; Spena R; Senni C; Scorcia V; Busin M
Curr Drug Targets; 2020; 21(12):1159-1180. PubMed ID: 32189591
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and lymphangiogenesis in corneal transplantation-A review.
Zhong W; Montana M; Santosa SM; Isjwara ID; Huang YH; Han KY; O'Neil C; Wang A; Cortina MS; de la Cruz J; Zhou Q; Rosenblatt MI; Chang JH; Azar DT
Surv Ophthalmol; 2018; 63(4):453-479. PubMed ID: 29287709
[TBL] [Abstract][Full Text] [Related]
18. Immunophysical analysis of corneal neovascularization: mechanistic insights and implications for pharmacotherapy.
Azimzade Y; Hong J; Mashaghi A
Sci Rep; 2017 Sep; 7(1):12220. PubMed ID: 28939878
[TBL] [Abstract][Full Text] [Related]
19. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
20. Corneal neovascularization: updates on pathophysiology, investigations & management.
Sharif Z; Sharif W
Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
